1. D-Glucuronolactone was converted into D-glucaro-(l -*4)-lactone, a glucuronidase inhibitor, probably via the intermediate D-glucaro-(1-.4)-(6-*3)-dilactone, by a dehydrogenase in human-liver extracts. 2. Similar experiments with mouse-liver extracts appeared to yield only D-glucaric acid or a non-inhibitory lactone. 3. A strong ,-glucuronidase inhibitor was present in mouse liver after the intraperitoneal administration of D-glucuronolactone. 4. D-Glucarodilactone decomposed spontaneously in aqueous solution to give 25% of D-glucaro-(l -÷4)-lactone; the percentage conversion was unaffected by human-liver homogenates. but considerably increased by mouse-liver or pig-liver fractions.
The presence of D-glucaric acid in normal mammalian urine (Marsh, 1963a; Ishidate, Matsui & Okada, 1965; Aarts, 1965) has been ascribed to the action of a dehydrogenase, present in liver and other tissues, on D-glucuronolactone (Marsh, 1963b) . It was suggested that the initial product of this enzymic oxidation was D-glucaro-(1 -4)-(6--3)-dilactone, which is readily convertible into Dglucaro-(1 --4)-lactone, a powerful fl-glucuronidase inhibitor. The natural occurrence of the (1-+4)-lactone, whether produced from endogenous free D-glucuronic acid or from administered D-glucuronolactone, would be ofparticular interest as an enzyme inhibitor of high specificity that could conceivably have a physiological role in the control of figlucuronidase action.
In the present work, the products of action of liver D-glucuronolactone dehydrogenase from different species were examined under conditions that would preserve any D-glucaro-(1 -*4)-lactone from spontaneous hydrolysis. Since the instability of D-glucarodilactone (Smith, 1944) precluded the possibility of its isolation and identification, the inhibitory properties of the final reaction products were compared with those of the decomposition products of synthetic D-glucarodilactone.
A preliminary communication ofpart of this work has already been published (Marsh, 1965 animals that were administered with D-glucuronolactone were all male, 10 weeks old, weight approx. 30g., and were starved for 24hr. before the treatment. Human-liver specimens, supplied by Dr A. J. Carr, Pathology Department, Aberdeen University, were from autopsy and were removed as soon as possible after death and stored at -20°. Fresh pig liver was obtained from Robert Lawson and Sons (Dyce) Ltd. Homogenates (10%, w/v) of these tissues were made in 0-17M-KCI and the particulate fraction was removed by centrifugation as described by Marsh & Carr (1965) . Partially purified D-glucuronolactonedehydrogenase was made from the supernatants as described by Marsh (1963b) . The standard rat-liver,B-glucuronidase preparation (Marsh, 1963a) was prepared from liver tissue of adult rats (hooded Lister strain) and used in the enzyme assays at a dilution of 1.2-31./g. of moist liver, depending on the pH employed.
Material. The sources of D-glucurono-(6-3)-lactone, potassium hydrogen D-glucarate, D-glucaro-(6-3)-lactone, D-glucaro-(--*4)-(6--3)-dilactone, NAD and phenolphthalein P-D-glucuronide were as previously described (Marsh, 1963c) . D-Glucarate solution was obtained by titrating a solution of the potassium salt with alkali to pH8-0. D-Glucaro-(1--4)-lactone monohydrate, m.p. 89-92°, was prepared by the method of Bose, Hullar, Lewis & Smith (1961) .
Procedures. Measurement of total D-glucaric acid (i.e. acid plus lactones) was as described by Marsh (1963a) , and of phenolphthalein liberated enzymically from its glucuronide as described by Levvy & Marsh (1959) . (Smith, 1944) to be a product of decomposition in aqueous solution. It seemed doubtful whether the dilactone itself had any inhibitory effect at the concentration employed.
EXPERIMENTAL AND RESULTS
The maximum percentage inhibitions by Dglucaro-(1 -4)-(6 -3)-dilactone of the rate of hydrolysis of the substrate, shown in Fig. 1 , were identical with those obtained when the dilactone was incubated for lhr. at 38°in buffer before the addition of substrate and enzyme, and then incubated for a further hour. From plots of the inhibition of rat-liver fl-glucuronidase by different concentrations of D-glucaro-(1 -+4)-lactone, equivalent concentrations of this compound required to produce the observed maximum inhibitory effects of 20,UM-D-glucarodilactone were derived, and were as follows: at pH6-0, 5-2,.M; at pH5-2, 4-6,uM; at pH4-5, 5-0Mm. Thus at these pH values approx. 25 % of the dilactone was apparently converted into D-glucarO-(1 -4)-lactone, which is stable under these conditions (Levvy, 1952) . Effects of preincubation of D-glucaro-(l -+4)-(6 -*3)-dilactone with liver-homogenate fraction8. In the presence of the soluble fractions of iso-osmotic liver homogenates in 0-17M-potassium chloride of some species, the production of ,-glucuronidase inhibitor from the decomposition of D-glucarodilactone appeared to be considerably greater than normal. The dilactone was incubated for 1 hr. with the liver fractions at pH 6-0, then phenolphthalein ,B-glucuronide added and the apparent ,-glucuronidase activity measured and compared with assays lacking the dilactone. The activity of this enzyme in pig liver was so low (see Conchie, Findlay & Levvy, 1959) that in this case it was necessary to add the standard rat-liver enzyme along with the substrate; the pig-liver extract was then also included in the controls. A pH value (6.0) higher than that for maximum enzyme activity (i.e. 4-5 or 5.2) was employed to prevent any conversion of D-glucarate into the inhibitory (1 -+4)-lactone during the incubation period. The results of these experiments are shown in Table 1 . After preincubation with the human-liver fraction, decomposition products of D-glucarodilactone had inhibitory activity identical with those from decomposition of the dilactone in buffer alone. However, in the presence of mouse-liver or pig-liver fractions the dilactone decomposed into products with considerably higher inhibitory power. There were differences in susceptibility to inhibition between the ,B-glucuronidases from different sources, and equivalent concentrations of Dglucaro-(l --4)-lactone necessary to give these (Fig. 2) inhibitory D-glucuronic acid (Levvy, 1952) by hydrolysis of its lactone thus had little effect. With the human enzyme, the rate of hydrolysis of phenolphthalein fl-glucuronide decreased continuously when NAD and D-glucuronolactone were present together. The activity of D-glucuronolactone dehydrogenase in the liver preparation at this pH is considerable although not optimum (see the Discussion section) and the estimated total D-glucaric acid (free acid plus lactones) concentration was 60pM in the illustrated experiment after 2hr., at which time the rate of hydrolysis was equivalent to inhibition by 16,UM-D-glucaro-(1 -*4)-lactone. The addition to the incubation mixture of 10 mM-n-pentanol, a strong inhibitor ofD -glucuronolactone dehydrogenase (Marsh, 1963c) , caused this decrease in the rate of phenolphthalein fl-glucuronide hydrolysis to disappear, and the total Dglucaric acid concentration was then 5 pM after 2 hr.
A similar experiment with the mouse-liver preparation gave very different results. The rate of hydrolysis of the substrate over 3 hr. was then constant (as in the upper line of Fig. 2 ) and unchanged by the addition of D-glucuronolactone and NAD to the incubation mixture. There was no evidence therefore for the production of an entity inhibitory to fi-glucuronidase in this case, although the total D-glucaric acid concentration produced after 3hr. was found to be 53DM when the two substrates for D-glucuronolactone dehydrogenase were included.
The inhibitory properties of the diffusible products of the action of human-liver and mouseliver D-glucuronolactone dehydrogenases were examined, and compared with those of the products from D-glucarate, D-glucaro-(1 -+4)-(6 -*3)-dilactone or D-glucaro-(6-÷3)-lactone incubated with the enzymes under the same conditions. The results are shown in Table 2 . During the period of dialysis (48hr. at 00), any D-glucaro-(1 --4)-(6--*3)-dilactone formed during the initial incubation would be completely converted into the monolactones. The product from oxidation of D-glucuronolactone with the human-liver enzyme had a strong inhibitory effect, but this inhibition was not appreciably affected by the treatment with acid at 1000, which would convert any D-glucarate present partially into the (1-*4)-lactone (Levvy, 1952) . However, inhibitory activity was destroyed by heating at a pH high enough to hydrolyse any lactones present, but was restored by subsequent acid treatment. This behaviour before and after the various treatments, was duplicated by the diffusible fraction from the incubation of D-glucaro-(1-4)-(6 -*3)-dilactone with the enzyme, whereas the products from incubations of D-glucarate or its (6-+3)-lactone were almost non-inhibitory unless suibjected to acid treatment, as was also the product 24 1966 ACTION OF GLUCURONOLACTONE DEHYDROGENASE Table 2 . Inhibitory effects of produet8 of human-liver and mouse-liver D-glucuronolactone dehydrogena8e8
Partially purified liver enzyme preparations (see the Methods and Materials section) were incubated with 5mM-D-glucuronolactone and 2-5mM-NAD, or with 0-25mM-D-glucaric acid (or its lactones), in 0 05M-phosphate buffer, pH6-0 (total volume lOml.), for 2hr. at 380, then dialysed against lOml. of water for 48hr. at 00. In each case, the diffusate (2 ml.) was: (A) adjusted to pH4-5; (B) adjusted to pH4*0, heated for 4Omin. at 100°, cooled and adjusted to pH4-5; (C) adjusted to pH7-5, heated for 15min. at 100°, cooled and adjusted to pH4-5; (D) adjusted to pH7-5, heated for 15min. at 100°, adjusted to pH4.0, heated for 40min. at 100°, cooled and adjusted to pH4-5.
Changes in pH were made with N-HCI or N-NaOH. The solutions (final volume 4-5ml.) were tested as inhibitors (diluted 1:1) of ,B-glucuronidase at pH5-2 with the standard rat-liver enzyme. Time after treatment (hr.) Fig. 3 . ,3-Glucuronidase activities (o) and D-glucaric acid contents (D) of soluble mouse-liver-homogenate fraction after a single intraperitoneal injection of D-glucuronolactone (1g./kg. body wt.). Enzyme assays were done at pH6-0 in 0-05M-phosphate buffer with 0-63mM-phenolphthalein /3-glucuronide. The concentration of enzyme preparation corresponded to 1-25% (w/v) moist tissue.
obtained with mouse-liver D-glucuronolactone dehydrogenase. Indeed, this last entity resembles more the product obtained from D-glucaro-(6-#3)-lactone rather than that from D-glucarate, in that higher inhibitions were obtained after preliminary heating with alkali followed by acid treatment than after acid treatment alone.
Production of Pf-glucuronida8e inhibitor in vivo by the administration of D-glucuronolactone. Single doses of D-glueuronolactone (1g./kg. body wt.) were given intraperitoneally to mice, the animals were killed after intervals and the livers removed immediately. ,B-Glucuronidase activities of the soluble fractions of liver homogenates in 0-17 Mpotassium chloride were then measured at pH 6-0. A sharp fall in enzyme activity was observed 20min. after treatment of the animals; after 40min. enzyme activity commenced to rise again and within 2hr. it had regained its original value (Fig. 3) . That this change in the fl-glucuronidase activity was due to the presence of an inhibitor, and not to a loss of the enzyme protein, was indicated by the fact that the relative magnitude ofthe change in enzyme activity varied with the concentration of the homogenate fraction in the assay. Whereas (total) D-glucaric acid was undetectable in normal livers, or in the livers of mice immediately after the injection of D -glueuronolactone, it was subsequently present in the tissue for periods up to 4hr. after the treatment (Fig. 3) . Maximum liver concentrations of D-glucaric acid were observed when the figlucuronidase activity was minimal, suggesting that the factor inhibiting fl-glucuronidase that developed after the treatment was D-glucaro-(1 -+4)-lactone.
DISCUSSION
The chemical formulae and transformations of compounds that may be implicated in this work are shown in Scheme 1. The D-glucaro-(1--4)-(6-*3)-dilactone (IV) that was used was a non-crystalline syrup obtained by dehydration of D-glucaro-(l -+4)-lactone (III) (Smith, 1944) . Harigaya (1964a) and Hirasaka & Umemoto (1965) have reported the isolation of crystalline products by this reaction and by dehydration of D-glucaro-(6 -> 3)-lactone (V) VOl. 99 25
